Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives

T Lazarević, A Rilak, ŽD Bugarčić - European journal of medicinal chemistry, 2017 - Elsevier
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …

Noble metals in medicine: Latest advances

S Medici, M Peana, VM Nurchi, JI Lachowicz… - Coordination Chemistry …, 2015 - Elsevier
History shows that metal-based drugs and remedies have been known and used since very
ancient times. For example, silver was employed in the treatment of wounds and ulcers …

[HTML][HTML] Bioactive glasses incorporating less-common ions to improve biological and physical properties

U Pantulap, M Arango-Ospina… - Journal of Materials …, 2022 - Springer
Bioactive glasses (BGs) have been a focus of research for over five decades for several
biomedical applications. Although their use in bone substitution and bone tissue …

Anti-cancer palladium complexes: a focus on PdX 2 L 2, palladacycles and related complexes

AR Kapdi, IJS Fairlamb - Chemical Society Reviews, 2014 - pubs.rsc.org
Much success has been achieved with platinum-based chemotherapeutic agents, ie through
interactions with DNA. The long-term application of Pt complexes is thwarted by issues …

Synthesis of palladium (II) complexes via Michael addition: antiproliferative effects through ROS-mediated mitochondrial apoptosis and docking with SARS-CoV-2

J Haribabu, S Srividya, D Mahendiran… - Inorganic …, 2020 - ACS Publications
Metal complexes have numerous applications in the current era, particularly in the field of
pharmaceutical chemistry and catalysis. A novel synthetic approach for the same is always a …

[HTML][HTML] Bioactivity and development of small non-platinum metal-based chemotherapeutics

MG Ferraro, M Piccolo, G Misso, R Santamaria, C Irace - Pharmaceutics, 2022 - mdpi.com
Countless expectations converge in the multidisciplinary endeavour for the search and
development of effective and safe drugs in fighting cancer. Although they still embody a …

Anticancer activity of palladium-based complexes against triple-negative breast cancer

M Vojtek, MPM Marques, IM Ferreira, H Mota-Filipe… - Drug Discovery …, 2019 - Elsevier
Highlights•TNBC is an unmet medical need with poor survival rates and no targeted
therapy.•TNBC resists conventional chemotherapy and surgical strategies.•A review of 121 …

[HTML][HTML] Metabolic aspects of palladium (II) potential anti-cancer drugs

TJ Carneiro, AS Martins, MPM Marques… - Frontiers in oncology, 2020 - frontiersin.org
This mini-review reports on the existing knowledge of the metabolic effects of palladium [Pd
(II)] complexes with potential anticancer activity, on cell lines and murine models. Most …

Comprehensive review on tumour active palladium compounds and structure–activity relationships

MN Alam, F Huq - Coordination Chemistry Reviews, 2016 - Elsevier
This article provides a comprehensive review of palladium compounds that have been
evaluated for anticancer activity in vivo or in vitro from the era of discovery of cisplatin up to …

Exploring the potential of metallodrugs as chemotherapeutics for triple negative breast cancer

N Nayeem, M Contel - Chemistry–A European Journal, 2021 - Wiley Online Library
This review focuses on studies of coordination and organometallic compounds as potential
chemotherapeutics against triple negative breast cancer (TNBC) which has one of the …